Investing.com -- Canadians are casting their ballots today in a volatile election cycle shaped by U.S. President Donald Trump ...

Shares of Protara Therapeutics, Inc. (NASDAQ: TARA) tumbled 19% after the company released interim results from its ongoing Phase 2 ADVANCED-2 trial of TARA-002 in patients with Non-Muscle Invasive ...